The University of Kansas Cancer Center

https://www.kucancercenter.org/

 

2021 Updates on MF: Addition of Parsaclisib in Patients With Suboptimal Response to Ruxolitinib

53 views
May 19, 2021
Comments 0
Login to view comments. Click here to Login